RadNet Inc (RDNT): Market Cap to Revenue Ratio

Brandmark of RadNet Inc (RDNT)

The P/S multiple reflects the valuation dynamics of RadNet, Inc. (RDNT), whose success is driven by the shift of patients from hospitals to the private sector. Aggressive expansion and the implementation of AI analytics are designed to increase service profitability. The value of 2.50 reflects this status, considering the business's dependence on insurance payouts, equipment costs, and the availability of specialized physicians.

RDNT RadNet Management Market Cap to Revenue (07/04/2022 - 11/13/2026)

Analytical breakdowns for RadNet Corp (RDNT)

- stock price and consensus target price:
Share Price radnet.com|RDNT - Price Target Chart
- stock exchange capitalization data:
Market Capitalization RadNet Corp|RDNT - Enterprise Value
- business book valuation details:
Net Asset Value per Share RadNet|RDNT - Company Net Assets|Market Cap to Book Value Multiple radnet.com|RDNT - Cumulative Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio RadNet, Inc.|RDNT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient RadNet Management|RDNT - Company Debts|Debt to Book Value Ratio RadNet Corp|RDNT - Company Long-Term Debts|Company Current Liabilities RadNet|Interim Coverage Ratio radnet.com
- earnings and multiples data:
RDNT - Company Net Income|Expected Net Income RadNet, Inc.|RDNT - P/E Multiple|Price to Future Earnings Ratio RadNet Inc|RDNT - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation RadNet Corp|RDNT - Operating profit before deduction of amortization|Earnings per share for the last four quarters RadNet|RDNT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months radnet.com|RDNT - Earnings per share growth in current year|Expected earnings per share trend next year RadNet, Inc.
- sales revenue and business income indicators:
RDNT - Revenue and Sales Volume|Company Expected Sales Volume radnet.com|RDNT - P/S Multiple|Forward P/S Multiple RadNet Corp
Fundamental company analysis:radnet.com (RDNT)
Finished products of RadNet, Inc.

Investors must determine whether the current valuation of RadNet, Inc. (RDNT) results from market undervaluation or signals a decline in business efficiency. The revenue multiple trend reflects the proportion between market capitalization and sales volume, where a declining ratio—coupled with continued optimization of diagnostic equipment logistics and reliable consumable supplies—confirms the asset's fundamental resilience and attractiveness.

Competing companies

hcahealthcare.com - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Tenet Healthcare Corporation THC|FMS: Market Cap to Revenue Ratio|Solventum Inc. - P/S Multiple|Price to Sales Encompass|UHS (uhsinc.com) - Market Cap to Revenue|DVA: Market Cap to Sales Volume|Market Cap to Revenue OPCH|SGRY: Market Capitalization-to-Revenue Ratio|P/S Multiple PINC|Price-to-Revenue Coefficient America's Best Contacts & Eyeglasses|Price-to-Revenue Ratio Progyny, Inc. PGNY|ARDT: Market Cap to Revenue Ratio|Select Medical Holdings - P/S Multiple|Astrana Health Inc (ASTH) - Market Cap to Revenue|MD (Pediatrix Medical Group, Inc.) - Market Cap to Revenue|USPH - Price-to-Revenue Coefficient|Price-to-Revenue Ratio The Pennant Group, Inc.|ORGO: Market Capitalization-to-Revenue Ratio|P/S Multiple NUTX|Auna S.A. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio SBC Medical Group Holdings Inc. SBC|EOLS: Market Cap to Revenue Ratio|CYH: Market Cap to Revenue|The Beauty Health - Market Cap to Sales Volume|MDWD (mediwound.com) - Market Cap to Revenue|BTMD: Market Cap to Sales Volume|Price-to-Revenue Ratio The Joint Corporation|DCGO: Market Capitalization-to-Revenue Ratio|P/S Multiple PIII|GANX - Price to Sales|P/S Multiple EUDA (EUDA Health Holdings Limited)|P/S Multiple Basel Medical BMGL|CLGN: Market Cap to Revenue|Cuprina Holdings Limited - Market Cap to Sales Volume|Concord Medical Services (CCM) - Price-to-Revenue Ratio|Market Cap to Revenue ashs.com|MRM (MEDIROM Healthcare Group) - P/S Multiple|Price to Sales Avalon GloboCare Corporation ALBT|Price-to-Revenue Ratio DIH Holding US Inc. (DHAI)|Carmell Corp - Market Cap to Revenue Ratio|NewGenIvf Group Limited - Market Cap to Revenue|Market Cap to Sales Volume ATIP (ATI Physical Therapy Inc.)|CMAX - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio KDLY (Kindly MD Inc)|MODV: P/S Multiple|Novo Integrated Sciences Corp (NVOS) - P/S Multiple|SSY (SunLink Health Systems Inc.) - P/S Multiple|Market Cap to Revenue Ratio BACK (imacholdings.comm)